Jove
Visualize
Contact Us

Related Experiment Videos

Current treatment options in aggressive lymphoma.

Robert Marcus1

  • 1Consultant Haematologist, Addenbrooke's Hospital, Cambridge, CB2 2QQ, UK. Robert.Marcus@addenbrookes.nhs.uk

Leukemia & Lymphoma
|May 25, 2004
PubMed
Summary

Improving long-term remission for aggressive non-Hodgkin's lymphoma (NHL) is crucial, as current CHOP chemotherapy offers only a 40% success rate. Novel strategies are needed, especially for elderly patients, to enhance treatment efficacy and reduce toxicity.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Minimal Residual Disease Status Predicts Outcome in Patients With Previously Untreated Follicular Lymphoma: A Prospective Analysis of the Phase III GALLIUM Study.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2023
Same author

Obinutuzumab Versus Rituximab Immunochemotherapy in Previously Untreated iNHL: Final Results From the GALLIUM Study.

HemaSphere·2023
Same author

Factors Affecting the Clinical Course of Follicular Lymphoma: A Multistate Survival Analysis Using Individual Patient Data from Eight Multicenter Randomized Clinical Trials.

Clinical lymphoma, myeloma & leukemia·2022
Same author

End of induction positron emission tomography complete response (PET-CR) as a surrogate for progression-free survival in previously untreated follicular lymphoma.

British journal of haematology·2022
Same author

Immunochemotherapy and Maintenance With Obinutuzumab or Rituximab in Patients With Previously Untreated Marginal Zone Lymphoma in the Randomized GALLIUM Trial.

HemaSphere·2022
Same author

Validation of POD24 as a robust early clinical end point of poor survival in FL from 5225 patients on 13 clinical trials.

Blood·2021
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Area of Science:

  • Hematology
  • Oncology
  • Clinical Research

Background:

  • Aggressive non-Hodgkin's lymphoma (NHL) has a suboptimal long-term remission rate of 40% with standard CHOP chemotherapy.
  • More intensive chemotherapy regimens have not improved survival and increase toxicity.
  • There is a critical need for improved treatment strategies for both primary therapy and relapsed NHL, particularly in elderly patients.

Purpose of the Study:

  • To review current challenges in treating aggressive non-Hodgkin's lymphoma (NHL).
  • To explore novel therapeutic approaches for improving patient outcomes.
  • To discuss the impact of new strategies on diffuse large B-cell lymphoma and mantle cell lymphoma.

Main Methods:

  • Review of existing literature on non-Hodgkin's lymphoma (NHL) treatment.
  • Analysis of current therapeutic strategies and their limitations.
  • Discussion of emerging treatment modalities and prognostic factor utilization.

Main Results:

  • Standard CHOP chemotherapy yields limited long-term remissions in aggressive NHL.
  • Intensified chemotherapy variants show no survival benefit and increased toxicity.
  • Novel approaches like risk stratification, high-dose therapy, autologous transplantation, immunotherapy, and radioimmunotherapy are under investigation.

Conclusions:

  • Current treatments for aggressive non-Hodgkin's lymphoma (NHL) are insufficient, necessitating innovative therapeutic strategies.
  • Personalized medicine approaches using prognostic factors can guide treatment decisions.
  • Integration of novel therapies holds promise for improving outcomes in aggressive NHL, especially for vulnerable patient populations.

Related Experiment Videos